Loomis, Sayles & Company
ABEV icon

Loomis, Sayles & Company’s Ambev ABEV Stock Holding History

Loomis, Sayles & Company’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.8M Buy
20,490,631
+1,189,814
+6% +$3.4M 0.08% 85
2025
Q4 		$47.7M Sell
19,300,817
-170,581
-0.9% -$406K 0.06% 109
2025
Q3 		$43.4M Buy
19,471,398
+1,379,164
+8% +$3.16M 0.05% 126
2025
Q2 		$43.6M Sell
18,092,234
-179,930
-1% -$438K 0.05% 122
2025
Q1 		$42.6M Buy
18,272,164
+396,898
+2% +$794K 0.06% 122
2024
Q4 		$33.1M Sell
17,875,266
-456,556
-2% -$1.01M 0.04% 177
2024
Q3 		$44.7M Sell
18,331,822
-559,283
-3% -$1.25M 0.06% 146
2024
Q2 		$38.7M Sell
18,891,105
-382,164
-2% -$870K 0.05% 155
2024
Q1 		$47.8M Sell
19,273,269
-483,159
-2% -$1.26M 0.07% 133
2023
Q4 		$55.3M Sell
19,756,428
-376,619
-2% -$1.02M 0.08% 110
2023
Q3 		$51.9M Sell
20,133,047
-718,479
-3% -$2.08M 0.09% 109
2023
Q2 		$66.3M Sell
20,851,526
-120,937
-0.6% -$356K 0.11% 91
2023
Q1 		$59.1M Buy
20,972,463
+230,731
+1% +$604K 0.1% 101
2022
Q4 		$56.4M Sell
20,741,732
-712,929
-3% -$2.08M 0.11% 96
2022
Q3 		$60.7M Sell
21,454,661
-2,323,786
-10% -$6.59M 0.12% 86
2022
Q2 		$59.7M Buy
23,778,447
+3,803,828
+19% +$10.8M 0.11% 88
2022
Q1 		$64.5M Sell
19,974,619
-1,437,641
-7% -$4.02M 0.09% 99
2021
Q4 		$60M Buy
21,412,260
+4,548,521
+27% +$13M 0.07% 122
2021
Q3 		$46.5M Sell
16,863,739
-35,692
-0.2% -$113K 0.06% 161
2021
Q2 		$58.1M Buy
16,899,431
+102,734
+0.6% +$334K 0.07% 125
2021
Q1 		$46M Buy
16,796,697
+1,753,342
+12% +$4.95M 0.06% 159
2020
Q4 		$46M Buy
15,043,355
+57,773
+0.4% +$156K 0.06% 143
2020
Q3 		$33.9M Sell
14,985,582
-1,061,218
-7% -$2.66M 0.05% 153
2020
Q2 		$42.4M Buy
16,046,800
+9,900,584
+161% +$23.4M 0.07% 109
2020
Q1 		$14.1M Sell
6,146,216
-17,425
-0.3% -$63K 0.03% 237
2019
Q4 		$28.7M Buy
6,163,641
+1,473,797
+31% +$6.54M 0.05% 154
2019
Q3 		$21.7M Buy
4,689,844
+131,583
+3% +$630K 0.04% 193
2019
Q2 		$21.3M Buy
4,558,261
+1,335,667
+41% +$5.98M 0.04% 203
2019
Q1 		$13.9M Buy
3,222,594
+237,001
+8% +$1.09M 0.03% 281
2018
Q4 		$11.7M Buy
2,985,593
+650,117
+28% +$2.77M 0.03% 282
2018
Q3 		$10.7M Buy
2,335,476
+876,488
+60% +$4.18M 0.02% 368
2018
Q2 		$6.75M Buy
1,458,988
+622,486
+74% +$3.66M 0.01% 499
2018
Q1 		$6.08M Buy
836,502
+198,936
+31% +$1.37M 0.01% 508
2017
Q4 		$4.12M Buy
637,566
+181,531
+40% +$1.16M 0.01% 533
2017
Q3 		$3M Buy
+456,035
New +$2.83M 0.01% 541

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $436M AUM 42.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company's ABEV Position: Q1 2026 in Review

Loomis, Sayles & Company increased its Ambev (ABEV) stake by 6.2% in Q1 2026, buying an estimated $3.4M and bringing the position to 20,490,631 shares worth $59.8M. The position accounts for 0.08% of the portfolio, ranked #85.

Loomis, Sayles & Company first reported a position in ABEV in Q3 2017 and has held it in 35 quarters since. The position peaked at $66.3M in Q2 2023. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Loomis, Sayles & Company held 20,490,631 shares of Ambev worth $59.8M as of Q1 2026.
  • Loomis, Sayles & Company bought 1,189,814 Ambev shares in Q1 2026, an estimated $3.4M.
  • Ambev made up 0.08% of Loomis, Sayles & Company's portfolio in Q1 2026, its #85 holding.
  • Loomis, Sayles & Company first reported a position in Ambev in Q3 2017 and has held it in 35 quarters since.
  • Loomis, Sayles & Company's Ambev position peaked at $66.3M in Q2 2023.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.